1. Short title This Act may be cited as the Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act . 2. Public reporting of procurement quotas for opioid analgesics (a) In general Section 306 of the Controlled Substances Act ( 21 U.S.C. 826 ) is amended by adding at the end the following: (i) (1) In this subsection, the term opioid procurement quota means a quota established by the Attorney General for the quantity of opioid analgesics that a registered manufacturer may procure for purposes of manufacturing dosage forms or other substances. (2) The Attorney General shall make publicly available, including through the Web site of the Drug Enforcement Administration— (A) the quantity of the opioid procurement quota for each registered manufacturer for each year; (B) the quantity of opioid analgesics procured by each registered manufacturer for each year; and (C) except as provided under paragraph (3)— (i) a copy of the form or other application, including any attachments or exhibits, submitted by each registered manufacturer requesting an opioid procurement quota